DEFICIENCY OF VITAMIN D IN PATIENT WITH PRIMARY HYPOTHYROIDISM AND AS RELATED RISK FACTOR FOR CARDIOVASCULAR DISEASES
Downloads
Hypothyroidism is believed to be associated with dyslipidemia and is considered a risk factor for the development of atherosclerotic cardiovascular diseases (ASCVD). Vitamin D, due to its steroid hormone action, retains cell function and controls the metabolism of lipids. Therefore, the present study was carried out to show the association of the risk factors of ASCVD. Cardiovascular disease (CVD) is caused by both clinical and subclinical hypothyroidism by disrupting healthy endothelial function by various mechanisms such as inflam- mation, triggering lipid disorders and oxidative stress. In the present study, a strong correlation was observed between increasing TSH and the parameters of lipid profile Hypothyroidism and hypovitaminosis D are known as inde-pendent risk factors for the development of cardiovascular diseases. Hypothyroidism and hypovitaminosis D are associated and correlated with total cholesterol, triglycerides, and low-density lipoprotein in Saudi patients. It is also recom- mended that vitamin D deficiency be checked in hypothyroid patients and that appropriate supplementation may be given if needed. Furthermore, for early detection and/or prediction of cardiovascular disease, screening of thyroid hormone and vitamin D levels should be undertaken at an early stage.
Holick MF (2007) Vitamin D, deficiency. N Engl J Med 357(3):266–281 2)Lips P. Vitamin D physiology. ProgBiophysMol Biol. 2006;92(1):4–8.
Hollick MF, Chen TC. Vitamin D deficiency is a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:10805–68.
Naeem Z. Vitamin D Deficiency- An Ignored Epidemic. Int J Health Sci (Qassim) 2010;4(1):5–6.
Deluca HF. Evolution of our understanding of vitamin D. Nutr Rev. 2008;66(10):73–87
Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med. 2005 Feb 3. 352(5):515-6; author reply 515-6.
Qamar J, Khan MD, Carol J, Fabian MD. How I Treat Vitamin D Deficiency. J Oncol Pract. 2010;6(2):97–101.
Liu BA, Gordon M, Labranche JM, et al. Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J Am Geriatr Soc. 1997 May. 45(5):598-603.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011 Jun 6.
Maretzke,F.;Bechthold,A.;Egert,S.;Ernst,J.B.;MelovanLent,D.;Pilz,S.;Reichr ath,J.;Stangl,G.I.;Stehle,P.;Volkert,D.;etal. Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review. Nutrients 2020, 12, 969.
M. Mackawy, B. M. Al-Ayed, and B. M. Al-Rashidi, “Vita- min d deficiency and its association with thyroid disease. Int J Health Sci (Qassim),” vol. 7, no. 3, pp. 267–275, 2013.
I.KleinandS.Danzi,“Thyroiddiseaseandtheheart,”Circula- tion, vol. 116, no. 15, pp. 1725–1735, 2007.
S. Savastio, E. Pozzi, F. Tagliaferri et al., “Vitamin D and car- diovascular risk: which implications in children?,” International Journal of Molecular Sciences, vol. 21, no. 10, p. 3536, 2020.
Charoenngam, N.; Holick, M.F. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020, 12, 2097.
Elamin, M.B.; Abu Elnour, N.O.; Elamin, K.B.; Fatourechi, M.M.; Alkatib, A.A.; Almandoz, J.P.; Liu, H.; Lane, M.A.; Mullan, R.J.; Hazem, A.; et al. Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2011, 96, 1931–1942.
Bolland, M.J.; Grey, A.; Gamble, G.D.; Reid, I.R. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014, 2, 307–320.
Dibaba, D.T. Effect of vitamin D supplementation on serum lipid profiles: A systematic review and meta-analysis. Nutr. Rev. 2019, 77, 890–902.
Manson, J.E.; Cook, N.R.; Lee, I.M.; Christen, W.; Bassuk, S.S.; Mora, S.; Gibson, H.; Gordon, D.; Copeland, T.; D’Agostino, D.; et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N. Engl. J. Med. 2019, 380, 33–44.
Bischoff-Ferrari, H.A.; Vellas, B.; Rizzoli, R.; Kressig, R.W.; da Silva, J.A.P.; Blauth, M.; Felson, D.T.; McCloskey, E.V.; Watzl, B.; Hofbauer, L.C.; et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. JAMA 2020, 324, 1855–1868.
Jahreis, G.; Hesse, V. Vitamin D-induced tissue calcinosis and arteriosclerosis changes. I: A contribution to the 60-year history of vitamin D research with special reference to childhood. Padiatr. Grenzgeb. 1990, 29, 203–211. (In German) [PubMed]
Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol. 2017, 70, 1–25
Pilz, S.; März, W.; Cashman, K.D.; Kiely, M.E.; Whiting, S.J.; Holick, M.F.; Grant, W.B.; Pludowski, P.; Hiligsmann, M.; Trummer, C.; et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front. Endocrinol. 2018, 9, 373.
E. E. Türemen, B. Çetinarslan, T. Sahin, Z. Cantürk, and I. Tarkun, “Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoim- mune thyroiditis,” Endocrine Journal, vol. 58, no. 5, pp. 349– 354, 2011.
A. Kumar, D. Suresh, V. Annam, and R. Srikrishna, “Signifi- cance of early biochemical markers of atherosclerosis in sub- clinical hypothyroidism patients with normal lipid profile,” International Journal of Biological and Medical Research, vol. 3, no. 4, pp. 2483–2486, 2012.
E. Cebeci, F. Alibaz-Oner, M. Usta, S. Yurdakul, and M. Erguney, “Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism,” Journal of Investigative Medicine, vol. 60, no. 1, pp. 23–28, 2015.
L. H. Duntas, “Thyroid disease and lipids,” Thyroid, vol. 12, no. 4, pp. 287–293, 2002
Y. Cai, M. M. Manio, G. P. Leung, A. Xu, E. H. Tang, and P. M. Vanhoutte, “Thyroid hormone affects both endothelial and vascular smooth muscle cells in rat arteries,” European Journal of Pharmacology, vol. 747, pp. 18–28, 2015.
R. Sabharwal, P. Mahajan, and A. Bhatia, “Association of sub- clinical hypothyroidism with dyslipidemia,” JK Science, vol. 19, no. 2, pp. 81–84, 2017.
M. D. S. Filgueiras, L. G. Suhett, M. A. Silva, N. P. Rocha, and J. F. de Novaes, “Lower vitamin D intake is associated with low HDL cholesterol and vitamin D insufficiency/deficiency in Brazilian children,” Public Health Nutrition, vol. 21, no. 11, pp. 2004–2012, 2018.
Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin Pharmacol. 2010;10(4):482–96.
Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid. 2011;21(8):891–96.
Cranney A, Horsley T, O’Donnell S. Effectiveness and Safety of Vitamin D in Relation to Bone Health. Evidence Reports/Technology Assessments. 2008;158:543–50.
Michael FH. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J ClinNutr. 2004;6(80):1678–88.
Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713–16.
Kaplan MM. Clinical perspectives in the diagnosis of thyroid disease. Clin Chem. 1999;45(8):1377–83.
Nicholas M, Robert H, Raynolds J. Spectroscopic Method for Quantitative Estimation of vitamin D. Ind Eng, Chem, Anal. ed. 1941;13940:227–31.
Vilarrasa N, Vendrell J, Maravall J, Elıo I, Solano E, San Jose E. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine. 2010;38(2):235–42
Copyright (c) 2024 Sura Sudad Sami, Fatima Ayad Nemeh, Maryam Ghassan Fakhry, Hala Thaer Kamal
This work is licensed under a Creative Commons Attribution 4.0 International License.
